ArticleFrontiers in oncology2026
Adjunctive photodynamic therapy improves outcomes and quality of life in condyloma acuminatum after radical cervical cancer surgery.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Condyloma acuminatum (CA), caused by human papillomavirus infection, frequently persists or recurs in patients undergoing treatment for cervical cancer and can significantly impair postoperative quality of life. Purpose: This study aimed to compare the efficacy of photodynamic therapy (PDT) combined with CO Methods: In this retrospective study, 148 patients were divided into a single laser group (n=81) receiving only CO Results: The combined PDT group demonstrated a significantly higher overall symptom relief rate (94.03% vs. 77.78%, P = 0.006) and lower recurrence rates at 3 months (7.46% vs. 24.69%) and 6 months (11.94% vs. 34.57%) compared to the single laser group. Greater improvements were observed in DLQI (10.46 vs. 11.73, P = 0.001), FSFI scores (25.09 vs. 23.83, P = 0.013), and across multiple EORTC QLQ-C30 domains-including physical, role, emotional, and social functioning, as well as global health status (all P<0.05) in the combined group. Viral load reduction was more pronounced (0.97 vs. 2.44 ×10 Conclusion: The addition of photodynamic therapy, a light-based immunomodulatory approach within photomedicine, enhances clinical outcomes and supports improved quality of life, potentially through synergistic cytotoxic and immune-mediated mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.